• 200 Citations
  • 7 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Anthony S. Rowe is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 22 Similar Profiles
Stroke Medicine & Life Sciences
etiracetam Medicine & Life Sciences
Pharmacy Students Medicine & Life Sciences
Warfarin Medicine & Life Sciences
Seizures Medicine & Life Sciences
Linezolid Medicine & Life Sciences
Factor VIIa Medicine & Life Sciences
Septic Shock Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2010 2019

Contrast-Induced Nephropathy in Ischemic Stroke Patients Undergoing Computed Tomography Angiography: CINISter Study

Rowe, A., Hawkins, B., Hamilton, L., Ferrell, A., Henry, J., Wiseman, B., Skovran, S. A., Mosadegh, M. S., Hare, M., Kocak, M. & Tolley, E., Mar 1 2019, In : Journal of Stroke and Cerebrovascular Diseases. 28, 3, p. 649-654 6 p.

Research output: Contribution to journalArticle

Confidence Intervals
Odds Ratio
Diabetes Mellitus
1 Citation (Scopus)

Current Practices of Intraventricular Antibiotic Therapy in the Treatment of Meningitis and Ventriculitis: Results from a Multicenter Retrospective Cohort Study

Lewin, J. J., Cook, A. M., Gonzales, C., Merola, D., Neyens, R., Peppard, W. J., Brophy, G. M., Kurczewski, L., Giarratano, M., Makii, J., Rowe, A., Tesoro, E. P., Zaniewski, A., Clark, S. & Ziai, W. C., Jun 15 2019, In : Neurocritical Care. 30, 3, p. 609-616 8 p.

Research output: Contribution to journalArticle

Cohort Studies
Retrospective Studies
Anti-Bacterial Agents
Central Nervous System Infections

Identification of Risk Factors for Refractory Status Epilepticus

Tatro, H. A., Hamilton, L. A., Peters, C. & Rowe, A., Jan 1 2019, (Accepted/In press) In : Annals of Pharmacotherapy.

Research output: Contribution to journalArticle

Status Epilepticus
Logistic Models
4 Citations (Scopus)

Activated prothrombin complex concentrate versus 4-factor prothrombin complex concentrate for vitamin K-antagonist reversal

Rowe, A., Dietrich, S. K., Phillips, J. W., Foster, K. E. & Canter, J. R., Jan 1 2018, In : Critical care medicine. 46, 6, p. 943-948 6 p.

Research output: Contribution to journalArticle

Vitamin K
International Normalized Ratio
prothrombin complex concentrates
Pharmacy Students
Pulmonary diseases
Lung Diseases